RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
| 07/31/2019 | 04/30/2019 | 01/31/2019 | 10/31/2018 | 07/31/2018 | |
|---|---|---|---|---|---|
| Net Income | -2.35M | -2.41M | -2.40M | -17.52M | -2.44M |
| Total Depreciation and Amortization | 605.20K | 361.10K | 578.80K | 1.41M | 28.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.04M | 1.29M | 966.90K | 13.02M | 822.10K |
| Change in Net Operating Assets | -379.10K | 105.50K | 2.00M | 2.97M | -3.19M |
| Cash from Operations | -1.08M | -654.60K | 1.14M | -115.10K | -4.78M |
| Capital Expenditure | -493.30K | -1.13M | -1.26M | -2.56M | -4.16M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -483.90K | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -493.30K | -1.13M | -1.26M | -3.05M | -4.16M |
| Total Debt Issued | 0.00 | 0.00 | 1.60M | -990.00K | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -200.00K | -200.00K | -- |
| Issuance of Common Stock | 2.52M | 2.78M | 97.50K | 4.36M | 8.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -985.20K | -52.00K | -752.50K | -52.80K | -553.10K |
| Cash from Financing | 1.16M | 2.04M | 559.30K | 2.39M | 5.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -417.70K | 261.20K | 445.20K | -766.70K | -2.99M |
